Pieris raises $50.6M in follow-on

Anticalin company Pieris Pharmaceuticals Inc. (NASDAQ:PIRS) raised $50.6 million through the sale of 6.3 million shares at $8 in a follow-on underwritten by Jefferies, Cowen and Evercore ISI. The figures include the sale of an 825,000 share overallotment on Feb. 16...